Ginsana and the flu
Ginsana® acts as an immunostimulant, boosting the natural immune response.
Let’s take the common cold or flu for example; 227 volunteers were asked to take 2 capsules of Ginsana each day or placebo, for 12 weeks. After the fourth week of treatment, they received a flu vaccination.
The proportion of volunteers catching influenza or cold was significantly lower in the Ginsana group. The levels of antibodies increased after vaccination and important immune cells were significantly higher after the 8th and the 12th week of treatment.1
The immune system: A recap
The immune systems consists of organs, cells, and molecules that fight infections. As humans, we have both innate (non-specific) immunity, and adaptive (specific) immunity. Your innate immunity is present at birth, and doesn’t require any ‘configuration. Your adaptive immunity on the other hand, develops after birth as a result of being exposed to different diseases or foreign cells. These are known as antigens.
Innate immunity Adaptive immunity
Physical and mechanical reactions such as the skin, coughing & vomiting
Immune cells that include mast cells, ciliated cells, cytokines and leukocytes
Other: Blood clots, lysozymes Two types of cells:
Th1 and Th2 cells – the delicate balance to fight infection
Also important to the immune response are the Th1 and Th2 cells (T helper cells), which are linked to the adaptive immunity defence system. Balancing these two types of cells is important, as depending on the situations (e.g. infections, allergy etc…) the immune system reacts differently.
It is very common, for example, for there to be an imbalance resulting in higher Th2 levels. This situation leads to a decreased ability to the body to fight against viruses and other pathogens, while making the body more susceptible to allergies, asthma and auto-immune diseases.
A shift of this balance in favour of the Th1 is desired for fighting intracellular or bacterial infections. Th1 cell types are known to be important in the defence against infections.6
Causes of this imbalance include factors like stress, infections, allergies and persistent pain.
How does Ginsana boost immunity
Ginsana has several effects on the immune system. Most of these influence the Th1 response, meaning that Ginsana® is able to rebalance the Th1 /Th2 ratio in favour of Th1, and consequently enhance the capacity of the body to fight against infections.
The restoration of the Th1/Th2 balance helps the body to react against infections from the beginning, preventing possible Upper Respiratory Tract Infections. It is not therefore surprising that clinical trials with Ginsana® demonstrated higher protection against common cold and flu, and supported the recovery after acute cases of bronchitis.
- Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardised Ginseng extract G115® for potentiating vaccination against common cold and/or influenza syndrome. Drugs Exptl Clin Res 1996 22(2):65-72 [S97-0584]
- Scaglione F, Ferrara F, Dugnani S, Falchi M, Santoro G, Fraschini F. Immunomodulatory effects of two extracts of Panax ginseng C. A. Meyer. Drugs Exptl Clin Res 1990 16(10):537-542 [S97-0532]
- Scaglione F, Cogo R, Cocuzza C, Arcidiacono M, Beretta A. Immunomodulatory effects of Panax ginseng C. A. Meyer (G115) on alveolar macrophages from patients suffering with chronic bronchitis. Int J Immunother 1994 10(1): 21-24 [S97-0568]
- Scaglione F,. Weiser K,. Alessandria M: Effects of the standardised ginseng extract G115Ò in patients with chronic bronchitis. A nonblinded, randomised, comparative pilot study. Clin Drug Invest 21(1), 41-45 (2001) [S01-0002]
- Gundling K; Brodsky Z; Schonfeld Y; Peter J; Patnaik M; Azari R; Gershwin ME; Robbins J Effects of Panax ginseng on antibody titres and quality of life after influenza vaccination. 8th Ann Symp on Complementary Health Care, Exeter, 6 - 8 Dec 2001 Focus Altern Complement Ther 7 (1) , 95 (2002) [S02-0087]
- Fearon, DT, Locksley RM, 1996. The instructive role of innate immunity in the acquired immune response. Science, 272: 50-53. [S16-0180]